The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Anticipated Rise In Market Value Of The Inhalation CDMO Market During The Forecast Period?
The inhalation cdmo market size has seen substantial growth in recent years. It is anticipated to increase from $2.2 billion in 2025 to $2.35 billion in 2026, at a compound annual growth rate (CAGR) of 6.4%. This historical expansion can be attributed to several factors, including the increasing prevalence of asthma and copd, a heightened demand for inhalation therapies, the development of biologics and specialized drug formulations, continuous advancements in formulation technologies, and the rising trend of outsourcing by pharmaceutical companies.
The inhalation cdmo market is projected to experience significant expansion in the coming years, with its size expected to reach $3.03 billion in 2030, growing at a compound annual growth rate (CAGR) of 6.6%. This anticipated growth throughout the forecast period is primarily driven by the proliferation of digital and smart inhalers, advancements in personalized medicine and precision therapy, increased capital expenditure in inhalation cdmo infrastructure, the growing adoption of sophisticated manufacturing technologies, and a rise in strategic partnerships between biotech companies and CDMOs. Prominent trends for the forecast period include the development of personalized inhalation therapies, the application of advanced formulation and drug delivery techniques, enhancements in regulatory compliance and quality assurance standards, an expansion of contract manufacturing services for small and medium-sized enterprises, and the integration of smart inhalers with digital health monitoring systems.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13864&type=smp
What Key Factors Are Affecting The Inhalation CDMO Market Demand?
The rising occurrence of respiratory illnesses is anticipated to fuel the expansion of the inhalation CDMO market in the future. These disorders encompass various medical conditions impacting the respiratory system, specifically the organs and structures essential for respiration. Inhalation CDMOs play a crucial role in creating and producing treatments for respiratory ailments, leveraging their proficiency in drug formulation and delivery to the lungs, and offering specialized expertise, infrastructure, and resources to pharmaceutical firms developing advanced inhalation therapies. For example, data from the National Library of Medicine, a US-based medical library, revealed in December 2023 that the worldwide incidence of chronic obstructive pulmonary disease (COPD) in individuals aged 25 and above is forecast to increase by 23% by 2050, potentially affecting almost 600 million people. Consequently, the growing frequency of respiratory conditions is propelling the development of the inhalation CDMO market.
How Is The Inhalation CDMO Market Broken Down By Segment Categories?
The inhalation cdmo market covered in this report is segmented –
1) By Product: Dry Powder Inhaler (DPIs), Metered Dose Inhaler (MDIs), Nebulizer, Soft Mist Inhaler
2) By Disease Indication: Asthma, Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Arterial Hypertension, Acute Respiratory Distress Syndrome, Pulmonary Fibrosis
3) By Technology: Manual Inhalers (SMI), Digital Inhalers
4) By End-User: Big Pharmaceutical Companies, Small and Medium-sized Pharmaceutical Companies, Generic Pharmaceutical Companies, Other End-Users
Subsegments:
1) By Dry Powder Inhaler (DPIs): Capsule-Based DPIs, Diskus-Style DPIs, Multi-Dose DPIs, Unit-Dose DPIs
2) By Metered Dose Inhaler (MDIs): Pressurized MDIs (pMDIs), Breath-Actuated MDIs, Soft Mist MDIs
3) By Nebulizer: Jet Nebulizers, Ultrasonic Nebulizers, Mesh Nebulizers, Portable Nebulizers
4) By Soft Mist Inhaler: Respimat Inhalers, Other Soft Mist Inhalation Devices
What Emerging Trends Are Seen In The Inhalation CDMO Market?
Leading companies within the inhalation CDMO sector are increasingly forming strategic alliances to deliver specialized drug development and delivery solutions. A strategic partnership denotes a long-standing, mutually beneficial arrangement between two or more entities collaborating to achieve common objectives. As an example, in May 2023, Hovione, a Contract Development and Manufacturing Organization situated in Portugal, joined forces with H&T Presspart, a UK-based producer of high-precision metal and plastic components for the pharmaceutical industry, to progress Presspart’s Sunrise Capsule-based Dry Powder Inhaler platform. This collaboration aims to innovate new technologies that facilitate the delivery of higher drug doses and enhance the efficiency of drug administration to the lungs.
Which Players Are Present In The Inhalation CDMO Market Space?
Major companies operating in the inhalation cdmo market are Baxter’s BioPharma Solutions, Lonza Group AG, Catalent Inc., Siegfried Holding AG, Recipharm AB, Stevanato Group SpA, CordenPharma, Nemera, Hovione FarmaCiencia SA, Vectura Group Ltd., CARBOGEN AMCIS, Kindeva Drug Delivery Ltd., Frontage Laboratories Inc, Sanner GmbH, H&T Presspart Ltd., Astech Projects Ltd, Cliantha Research, Copley Scientific, Cambrex Corporation, AptarGroup Inc.
Get The Full Inhalation CDMO Market Report:
https://www.thebusinessresearchcompany.com/report/inhalation-cdmo-global-market-report
Which Region Is The Leading Market For The Inhalation CDMO Market?
North America was the largest region in the inhalation contract development and manufacturing organization (CDMO) market in 2025. The regions covered in the inhalation cdmo market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Inhalation CDMO Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/inhalation-cdmo-global-market-report
Browse Through More Reports Similar to the Global Inhalation CDMO Market 2026, By The Business Research Company
Inhalation Cdmo Market Report 2026
https://www.thebusinessresearchcompany.com/report/inhalation-cdmo-global-market-report
Inhalable Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/inhalable-drugs-global-market-report
Inhalation Anesthesia Market Report 2026
https://www.thebusinessresearchcompany.com/report/inhalation-anesthesia-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model